A novel PRKAG2 mutation in a Chinese family with cardiac hypertrophy and ventricular pre-excitation

作者：Yang, Kun-Qi; Lu, Chao-Xia; Zhang, Ying; Yang, Yan-Kun; Li, Jia-Cheng; Lan, Tian; Meng, Xu; Fan, Peng; Tian, Tao; Wang, Lin-Ping; Liu, Ya-Xin; Zhang, Xue^*; Zhou, Xian-Liang^*

来源：Scientific Reports, 2017, 7(1): 2407.

DOI：10.1038/s41598-017-02455-z

• ACTIVATED PROTEIN-KINASE
• CARDIOVASCULAR MAGNETIC-RESONANCE
• CONDUCTION SYSTEM DISEASE
• GLYCOGEN-STORAGE-DISEASE
• PARKINSON-WHITE-SYNDROME
• MOUSE MODEL
• CARDIOMYOPATHY
• SUBUNIT
• PATHWAY
• GAMMA-2-SUBUNIT

PRKAG2 syndrome is a rare autosomal dominant inherited disorder that is characterized by cardiac hypertrophy, ventricular pre-excitation and conduction system abnormalities. There is little knowledge in cardiovascular magnetic resonance (CMR) characteristics of PRKAG2 cardiomyopathy. This study investigated the genetic defect in a three-generation Chinese family with cardiac hypertrophy and ventricular pre-excitation using whole-exome sequencing. A novel missense mutation, c.1006 G > T (p.V336L), was identified in PRKAG2. This mutation had not been identified in the ExAC database, and the prediction result of MutationTaster indicated a deleterious effect. Furthermore, it cosegregated with the disease in the present family and was absent in unrelated 300 healthy controls. cDNA analysis did not detect any splicing defects, although the variant occurred in the first base of exon 9. CMR evaluation in five affected members showed diffuse hypertrophy in a concentric pattern, with markedly increased left ventricular mass above age and gender limits (median 151.3 g/m(2), range 108.4-233.4 g/m(2)). Two patients in progressive stage and one patient with sudden cardiac death exhibited extensive subendocardial late gadolinium enhancement. In conclusion, molecular screening for PRKAG2 mutations should be considered in patients who exhibit cardiac hypertrophy coexisting with ventricular pre-excitation. CMR offers promising advantages for evaluation of PRKAG2 cardiomyopathy.

• 出版日期2017-5-25
• 单位中国医学科学院北京协和医院; 中国医学科学院阜外医院; 北京协和医学院; 医学分子生物学国家重点实验室